Definium Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $12.3M | $164.0M | $133.5M |
| FY2022 | $19.1M | $170.0M | $142.1M |
| FY2023 | $46.4M | $124.5M | $99.7M |
| FY2024 | $60.7M | $302.2M | $273.7M |
| FY2025 | $107.8M | $440.1M | $257.8M |